The role of tissue kallikrein 1 in hematopoietic stem cell transplant-associated thrombotic microangiopathy |
Baylor College of Medicine / Sarah Sartain, MD |
Innovation Grants |
2024 |
Texas |
Targeting of a putative unresolved wound healing process in childhood ependymoma |
University of Colorado Denver / Nicholas Foreman, MD |
Innovation Grants |
2024 |
Colorado |
Development of CAR-T therapy for Ewing sarcoma using zebrafish in vivo models |
Children’s Hospital Los Angeles / James Amatruda, MD/PhD |
Innovation Grants |
2024 |
California |
Development of allogeneic off-the-shelf gamma delta T cell product for pediatric AML |
Baylor College of Medicine / Norihiro Watanabe, PhD |
Innovation Grants |
2024 |
Texas |
DMG: From SWI/SNF’s role in cholesterol biosynthesis to new therapeutic opportunities |
Board of Trustees of the Leland Stanford Junior University / Capucine Van Rechem, PhD |
Innovation Grants |
2024 |
California |
Unraveling the Mechanisms of Inherited Predisposition to Childhood Leukemia |
Boston Children’s Hospital / Vijay Sankaran, MD/PhD |
Innovation Grants |
2024 |
Massachusetts |
Pathological Condensates and Transcription Dysregulation in Rhabdomyosarcoma at Single-Molecule Resolution |
California Institute of Technology / Shasha Chong, PhD |
Innovation Grants |
2024 |
California |
Direct targeting of oncoprotein assembly using mimetic peptide interference |
Memorial Sloan-Kettering Cancer Center / Alex Kentsis, MD/PhD |
Innovation Grants |
2024 |
New York |
Collective cell invasion of fusion positive rhabdomyosarcoma regulated by PAX3-FOXO1 |
Children’s Hospital Los Angeles / Jinseok Park, PhD |
'A' Award Grants |
2024 |
California |
Gene-mediated cytotoxic immunotherapy in pediatric patients with recurrent malignant brain tumors |
University of Michigan / Andrea Franson, MD |
'A' Award Grants |
2024 |
Michigan |